Where do Roivant Sciences's ratios come from?

Every ratio is computed from Roivant Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Roivant Sciences ROIV Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25	TTM Q4 '24
Profitability
Free cash flow margin	-22,499.4%-12,970pp	-16,221.1%-8,059pp	-13,015%-5,354pp	-11,265.2%-3,703pp	-9,529.9%-2,274pp
Efficiency
Asset turnover	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Liquidity
Current ratio	123.3×+13.6×	138.4×+36.9×	145.6×+54.3×	122.3×+35.6×	109.7×+44.5×
Quick ratio	123.3×+13.7×	138.4×+37.2×	145.6×+54.6×	122.3×+35.9×	109.6×+44.5×
Cash ratio	7.2×-20.8×	2.8×-25.3×	2.9×-51.8×	2.4×-57.4×	28×-11.2×
Leverage
Debt-to-equity	0.1×0.0×	0.1×-0.1×	0.1×-0.2×	0.1×-0.7×	0.1×-1.1×
Debt-to-assets	0.1×0.0×	0.1×-0.1×	0.1×-0.1×	0.1×-0.4×	0.1×-0.5×
Per Share
Book value per share	$25.45-7.8%	$25.38-10.4%	$26.44-6.8%	$27.04+19.7%	$27.60+64.1%
Valuation
Market capitalization	$53.09B+65.5%	$40.47B+21.4%	$33.99B+0.8%	$32.15B-6.1%	$32.08B-6.2%
Enterprise value	$51.8B+94.0%	$40.49B+43.2%	$34B+51.3%	$32.09B+45.0%	$26.7B+0.9%
Price / sales	4,379.9×+3,406×	2,227.6×+1,332×	1,376×+542×	1,097×+280×	974.1×+220×
Price / book	12.1×+5.8×	9.2×+3.1×	7.4×+1.4×	6.6×-7.2×	6.3×-14.6×
EV / sales	4,222.4×+3,397×	2,229.2×+1,475×	1,376.3×+836×	1,095.6×+592×	825.7×+257×
Free cash flow yield	-27.4%+11.7pp	-35.3%+1.1pp	-39.3%-2.6pp	-40.9%-3.9pp	-39.1%-0.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Roivant Sciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Roivant Sciences's ratios come from?: Every ratio is computed from Roivant Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.